stars 1 stars 2 stars 3

Aspire BioScience (“AspireBio”) is a wholly owned subsidiary of Exxel Pharma, Inc. The Company is focused on development its two lead therapeutics, URB937 and URB597, which were developed at the University of California, Irvine (UCI). Both molecules modulate natural endocannabinoid signaling, and have significant, transformative clinical and commercial potential in diseases with substantial unmet medical needs.

Aspire BioScience Questions

Aspire BioScience is based in Boulder, Colorado.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users